• Curiochips develops 3D vascularized organ-on-a-chip that can function as a drug screening platform via micro-blood vessel networks for pre-clinical drug experiments. Liquid capillarity of curioslide (first microplate product name of Curiochips) microstructure enables an autonomous 3D cell/hydrogel patterning without needing additional accessories or experimental equipment.
  • Homepage :
  • Recent Financing Round : $6.2M Series A in January 2021
  • Other Investors : Winvest Venture Capital, HG Initiative (HGI)
  • Portfolio company : SparkLabs Korea

BACK Website